FDA Advisory Committee votes on investigational medicine metreleptin
- Details
- Category: AstraZeneca

Multimillion pound investment in UK life sciences research and development
- Details
- Category: UCB

Pfizer expands clinical trial data access policy and launches data access portal
- Details
- Category: Pfizer

Novartis Africa Day highlights company's efforts to expand access to healthcare
- Details
- Category: Novartis

Only 29% of people with diabetes report that their doctors ask them for input for their own treatment plans
- Details
- Category: Novo Nordisk

New study showed significant reduction in blood glucose with Linagliptin alone and in combination with metformin
- Details
- Category: Boehringer Ingelheim

Pfizer acquires Polocard, Poland's leading over-the-counter heart attack prevention brand
- Details
- Category: Pfizer

More Pharma News ...
- Novartis Foundation launches new leprosy strategy at symposium on disease elimination
- GSK responds to FDA decision on Avandia (rosiglitazone)
- Novartis highlights growth prospects driven by significant R&D pipeline progress and the expected increase in blockbuster treatments
- H5N1 vaccine approved by the U.S. FDA as pandemic influenza preparedness measure
- Pfizer and GSK to initiate study of novel combination therapy in patients with melanoma
- Bayer CEO Marijn Dekkers calls for greater appreciation of innovation
- Five inspirational organisations from Malawi, Bangladesh, Mali, Kenya, and Colombia recognised by GSK and Save the Children